MediPharm Labs (TSE:LABS) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MediPharm Labs reported a significant improvement in its financial results for the third quarter, with net revenue rising by 15% and gross profit improving by 29% compared to the previous year. The company has also paid off all its convertible debt, allowing it to focus on expanding in international markets, particularly Germany and Australia, where it has seen substantial growth.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue